These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3665047)

  • 41. Defining allowable total error limits in the clinical laboratory.
    Palmer J; Galior K
    Adv Clin Chem; 2024; 118():205-223. PubMed ID: 38280806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay.
    Rifai N; Cole TG; Iannotti E; Law T; Macke M; Miller R; Dowd D; Wiebe DA
    Clin Chem; 1998 Jul; 44(7):1452-8. PubMed ID: 9665423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AUDILAB: a knowledge-based quality audit simulator for testing laboratories.
    Brai A; Garnerin P
    Comput Biol Med; 1997 May; 27(3):201-10. PubMed ID: 9215482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nordic surveys of analytical quality in clinical chemistry laboratories.
    Solberg HE; Björkhem I; Skrede S
    Scand J Clin Lab Invest Suppl; 1984; 172():103-13. PubMed ID: 6599511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The contribution of proficiency testing to improving laboratory performance and ensuring quality patient care.
    Johnson PR
    Clin Leadersh Manag Rev; 2004; 18(6):335-41. PubMed ID: 15597555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality control of drug assays.
    Ayers G; Burnett D; Griffiths A; Richens A
    Clin Pharmacokinet; 1981; 6(2):106-17. PubMed ID: 7011655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systems approach to assure optimal proficiency testing in the hematology laboratory.
    Cembrowski GS; Engebretson MJ; Hackney JR; Carey RN
    Clin Lab Med; 1993 Dec; 13(4):973-85. PubMed ID: 8313692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental validation of peptide immunohistochemistry controls.
    Bogen SA; Vani K; McGraw B; Federico V; Habib I; Zeheb R; Luther E; Tristram C; Sompuram SR
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):239-46. PubMed ID: 19077907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of factor XI activity testing in North American Specialized Coagulation Laboratories.
    Zantek ND; Hsu P; Meijer P; Smock KJ; Plumhoff EA; Refaai MA; Van Cott EM
    Int J Lab Hematol; 2015 May; 37 Suppl 1():99-107. PubMed ID: 25976967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-lymphocyte immunophenotyping blind proficiency testing: a model system for CD4+ T-cells.
    Francis DP; Peddecord KM; Hofherr LK; Benenson AS; Taylor RN; Schalla WO
    Clin Lab Sci; 1999; 12(5):278-89. PubMed ID: 10623327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should quality goals be defined for multicenter laboratory testing? Lessons learned from a pilot survey on a national surveillance program for diabetes.
    Wang L; Mo N; Pang R; Deng Q; Liu Y; Hu Y; Hu C; Wang L
    Int J Qual Health Care; 2016 Apr; 28(2):259-63. PubMed ID: 26796487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Quality assurance for analytical laboratories].
    Cwiek-Ludwicka K; Karłowski K
    Rocz Panstw Zakl Hig; 1993; 44(2-3):123-32. PubMed ID: 8016532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How well should laboratories perform in proficiency tests.
    Gardner M; Dobbs T
    J Environ Monit; 2004 Jun; 6(6):559-62. PubMed ID: 15173909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating Laboratory Performance on Point-of-Care Glucose Testing with Six Sigma Metric for 151 Institutions in China.
    Fei Y; Wang W; He F; Zhong K; Wang Z
    Diabetes Technol Ther; 2015 Oct; 17(10):745-54. PubMed ID: 26355758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proficiency testing/external quality assessment: current challenges and future directions.
    Miller WG; Jones GR; Horowitz GL; Weykamp C
    Clin Chem; 2011 Dec; 57(12):1670-80. PubMed ID: 21965556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.
    Hillarp A; Egberg N; Nordin G; Stigendal L; Fagerberg I; Lindahl TL
    Thromb Haemost; 2004 Feb; 91(2):300-7. PubMed ID: 14961158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How good are clinical laboratories? An assessment of current performance.
    Rej R; Jenny RW
    Clin Chem; 1992 Jul; 38(7):1210-7; discussion 1218-25. PubMed ID: 1623585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interlaboratory quality control in gynecologic cytopathology using the novel CONQUISTADOR software. Interobserver reproducibility in the Latin American screening study.
    Alderisio M; Branca M; Erzen M; Longatto-Filho A; Derchain S; Tatti S; Vighi S; Roteli-Martins C; Leoncini L; Maeda MY; Montis D; Gontijo R; Sarian LO; Syrjänen K
    Acta Cytol; 2007; 51(6):872-81. PubMed ID: 18077979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proficiency testing of allergen measurements in residential dust.
    Pate AD; Hamilton RG; Ashley PJ; Zeldin DC; Halsey JF
    J Allergy Clin Immunol; 2005 Oct; 116(4):844-50. PubMed ID: 16210059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.